United States Biotechnology & Medical Research

Artiva Biotherapeutics Inc (ARTV)

Track

Track

Artiva Biotherapeutics experienced significant insider trading activity recently. While RA Capital Management executed substantial share purchases, executive leadership, including CEO Fred Aslan, conducted multiple planned sales. These transactions follow the company's August results financiers, with the stock price currently trading at a moderate percentile relative to its annual range.
Ticker: ARTV Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Artiva Biotherapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.3
Aslan Fred Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
447.12
Quantity 69,048 +2.7%
Value US$818,597
1.3
FRED ASLAN Director; Officer Executive Director
Transaction date
Proposed sale
Price
333.60
Quantity 77,366
Value US$374,436
1.3
Banerjee Subhashis Chief Medical Officer Officer
Transaction date
Sale
Price
99.18
Quantity 97,930 +45.9%
Value US$3,492,153
1.3
Bush Jennifer COO, CLO, Compliance Officer Officer
Transaction date
Sale
Price
11.16
Quantity 8,391 -2.5%
Value US$93,606
1.3
Horan Christopher Chief Tech Operations Officer Officer
Transaction date
Sale
Price
11.16
Quantity 10,366 -3.5%
Value US$115,638
1.3
Aslan Fred Chief Executive Officer Executive Director
Transaction date
Sale
Price
11.16
Quantity 61,888 -4.0%
Value US$690,392
1.3
Banerjee Subhashis Chief Medical Officer Officer
Transaction date
Planned sale
Price
12.01
Quantity 8,222 -5.5%
Value US$98,736
1.3
SUBHASHIS BANERJEE Officer Officer
Transaction date
Proposed sale
Price
11.77
Quantity 7,818
Value US$92,018
1.3
Banerjee Subhashis Chief Medical Officer Officer
Transaction date
Planned sale
Price
12.00
Quantity 429 -0.3%
Value US$5,148
1.3
SUBHASHIS BANERJEE Officer Officer
Transaction date
Proposed sale
Price
11.74
Quantity 833
Value US$9,779
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
9.93
Quantity 24,944 +0.1%
Value US$247,694
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
9.99
Quantity 20,824 +0.1%
Value US$208,032
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
9.99
Quantity 41,319 +0.2%
Value US$412,777
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
9.96
Quantity 59,880 +0.3%
Value US$596,405
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
9.93
Quantity 84,124 +0.5%
Value US$835,351
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
9.55
Quantity 120,582 +0.7%
Value US$1,151,558
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
8.95
Quantity 7,882 +0.0%
Value US$70,544
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
8.93
Quantity 152,472 +0.9%
Value US$1,361,575
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
8.94
Quantity 6,552 +0.0%
Value US$58,575
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
8.97
Quantity 15,102 +0.1%
Value US$135,465
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
8.98
Quantity 1,876 +0.0%
Value US$16,846
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
8.88
Quantity 31,000 +0.2%
Value US$275,280
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
8.89
Quantity 124,893 +0.8%
Value US$1,110,299
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
8.99
Quantity 15,414 +0.1%
Value US$138,572
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
8.57
Quantity 391,019 +2.4%
Value US$3,351,033
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
7.91
Quantity 548,580 +3.5%
Value US$4,339,268
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
7.91
Quantity 548,580 +3.5%
Value US$4,339,268
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
7.00
Quantity 103 +0.0%
Value US$721
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
7.00
Quantity 103 +0.0%
Value US$721
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
6.91
Quantity 479,039 +3.2%
Value US$3,310,159
1.3
Horan Christopher Chief Tech Operations Officer Officer
Transaction date
Sale
Price
9.01
Quantity 7,002 -2.3%
Value US$63,073
1.3
Aslan Fred Chief Executive Officer Executive Director
Transaction date
Sale
Price
9.01
Quantity 27,116 -1.7%
Value US$244,253
1.3
Banerjee Subhashis Chief Medical Officer Officer
Transaction date
Sale
Price
9.01
Quantity 7,037 -4.6%
Value US$63,386
1.3
Bush Jennifer COO, CLO, Compliance Officer Officer
Transaction date
Sale
Price
9.01
Quantity 8,790 -2.5%
Value US$79,179
1.3
Raymon Heather SVP, Research and Development Officer
Transaction date
Sale
Price
9.01
Quantity 3,095 -2.0%
Value US$27,879
1.3
Fred Aslan, M.D. Officer; Director Executive Director
Transaction date
Proposed sale
Price
9.22
Quantity 28,000
Value US$258,160
1.3
Subhashis Banerjee Officer; Director Executive Director
Transaction date
Proposed sale
Price
9.22
Quantity 7,000
Value US$64,540
1.3
Jennifer Bush Officer; Director Executive Director
Transaction date
Proposed sale
Price
9.22
Quantity 9,000
Value US$82,980
1.3
Heather Raymon Officer; Director Executive Director
Transaction date
Proposed sale
Price
9.22
Quantity 3,500
Value US$32,270
1.3
Christopher P. Horan Officer; Director Executive Director
Transaction date
Proposed sale
Price
9.22
Quantity 7,500
Value US$69,150
1.3
GC Corp. Large shareholder
Transaction date
Purchase
Price
11.52
Quantity 347,222 +27.5%
Value US$3,999,997
1.3
GC Corp. Large shareholder
Transaction date
Purchase
Price
11.52
Quantity 1,085,069 +32.8%
Value US$12,499,995
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
11.52
Quantity 6,510,416 +74.9%
Value US$74,999,992
1.3
FRED ASLAN Director; Officer Executive Director
Transaction date
Proposed sale
Price
3.30
Quantity 12,749
Value US$42,072
1.3
Aslan Fred President and CEO Executive Director
Transaction date
Planned sale
Price
6.00
Quantity 3,187 -0.3%
Value US$19,122
1.3
FRED ASLAN Director; Officer Executive Director
Transaction date
Proposed sale
Price
3.25
Quantity 6,375
Value US$20,719
1.3
Aslan Fred President and CEO Executive Director
Transaction date
Planned sale
Price
3.38
Quantity 6,375 -1.8%
Value US$21,522
1.3
FRED ASLAN Director; Officer Executive Director
Transaction date
Proposed sale
Price
2.77
Quantity 25,500
Value US$70,635
1.3
Aslan Fred President and CEO Executive Director
Transaction date
Planned sale
Price
6.00
Quantity 25,500 -6.7%
Value US$153,000
1.3
Aslan Fred President and CEO Executive Director
Transaction date
Planned sale
Price
2.73
Quantity 25,500 -6.2%
Value US$69,579
1.3
FRED ASLAN Director; Officer Executive Director
Transaction date
Proposed sale
Price
2.70
Quantity 25,500
Value US$68,850
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
12.00
Quantity 688,326 +497.0%
Value US$8,259,912
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
12.00
Quantity 7,645,007 +729.1%
Value US$91,740,084
2.6
5AM Partners VI, LLC Large shareholder
Transaction date
Purchase
Price
12.00
Quantity 833,333 +239.0%
Value US$9,999,996
1.3
GC Corp. Large shareholder
Transaction date
Purchase
Price
12.00
Quantity 416,666 +49.4%
Value US$4,999,992
1.3
GC Corp. Large shareholder
Transaction date
Purchase
Price
12.00
Quantity 1,666,666 +101.6%
Value US$19,999,992
0.8
Huh Yong-Jun Non-Executive Director
Transaction date
Purchase
Price
12.00
Quantity 416,666 +49.4%
Value US$4,999,992
0.8
Huh Yong-Jun Non-Executive Director
Transaction date
Purchase
Price
12.00
Quantity 1,666,666 +101.6%
Value US$19,999,992
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-09 2026-09-08 PlS Planned sale
1.3
Aslan Fred

Chief Executive Officer

Executive Director
69,048 +2.7%
447.12
US$818,597 		69,048 +2.7% 447.12 US$818,597
2026-09-08 2026-09-08 PrS Proposed sale
1.3
FRED ASLAN

Director; Officer

Executive Director
77,366
333.60
US$374,436 		77,366 333.60 US$374,436
2026-09-04 2026-09-03 S Sale
1.3
Banerjee Subhashis

Chief Medical Officer

Officer
97,930 +45.9%
99.18
US$3,492,153 		97,930 +45.9% 99.18 US$3,492,153
2026-09-04 2026-09-03 S Sale
1.3
Bush Jennifer

COO, CLO, Compliance Officer

Officer
8,391 -2.5%
11.16
US$93,606 		8,391 -2.5% 11.16 US$93,606
2026-09-04 2026-09-03 S Sale
1.3
Horan Christopher

Chief Tech Operations Officer

Officer
10,366 -3.5%
11.16
US$115,638 		10,366 -3.5% 11.16 US$115,638
2026-09-04 2026-09-03 S Sale
1.3
Aslan Fred

Chief Executive Officer

Executive Director
61,888 -4.0%
11.16
US$690,392 		61,888 -4.0% 11.16 US$690,392
2026-08-31 2026-08-27 PlS Planned sale
1.3
Banerjee Subhashis

Chief Medical Officer

Officer
8,222 -5.5%
12.01
US$98,736 		8,222 -5.5% 12.01 US$98,736
2026-08-27 2026-08-27 PrS Proposed sale
1.3
SUBHASHIS BANERJEE

Officer

Officer
7,818
11.77
US$92,018 		7,818 11.77 US$92,018
2026-08-19 2026-08-18 PlS Planned sale
1.3
Banerjee Subhashis

Chief Medical Officer

Officer
429 -0.3%
12.00
US$5,148 		429 -0.3% 12.00 US$5,148
2026-08-18 2026-08-18 PrS Proposed sale
1.3
SUBHASHIS BANERJEE

Officer

Officer
833
11.74
US$9,779 		833 11.74 US$9,779
2026-07-31 2026-07-31 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
24,944 +0.1%
9.93
US$247,694 		24,944 +0.1% 9.93 US$247,694
2026-07-31 2026-07-29 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
20,824 +0.1%
9.99
US$208,032 		20,824 +0.1% 9.99 US$208,032
2026-07-28 2026-07-24 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
41,319 +0.2%
9.99
US$412,777 		41,319 +0.2% 9.99 US$412,777
2026-07-23 2026-07-23 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
59,880 +0.3%
9.96
US$596,405 		59,880 +0.3% 9.96 US$596,405
2026-07-23 2026-07-22 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
84,124 +0.5%
9.93
US$835,351 		84,124 +0.5% 9.93 US$835,351
2026-07-23 2026-07-21 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
120,582 +0.7%
9.55
US$1,151,558 		120,582 +0.7% 9.55 US$1,151,558
2026-07-20 2026-07-17 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
7,882 +0.0%
8.95
US$70,544 		7,882 +0.0% 8.95 US$70,544
2026-07-20 2026-07-16 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
152,472 +0.9%
8.93
US$1,361,575 		152,472 +0.9% 8.93 US$1,361,575
2026-07-14 2026-07-13 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
6,552 +0.0%
8.94
US$58,575 		6,552 +0.0% 8.94 US$58,575
2026-07-14 2026-07-10 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
15,102 +0.1%
8.97
US$135,465 		15,102 +0.1% 8.97 US$135,465
2026-06-29 2026-06-26 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
1,876 +0.0%
8.98
US$16,846 		1,876 +0.0% 8.98 US$16,846
2026-06-29 2026-06-25 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
31,000 +0.2%
8.88
US$275,280 		31,000 +0.2% 8.88 US$275,280
2026-06-16 2026-06-16 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
124,893 +0.8%
8.89
US$1,110,299 		124,893 +0.8% 8.89 US$1,110,299
2026-06-16 2026-06-15 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
15,414 +0.1%
8.99
US$138,572 		15,414 +0.1% 8.99 US$138,572
2026-06-16 2026-06-12 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
391,019 +2.4%
8.57
US$3,351,033 		391,019 +2.4% 8.57 US$3,351,033
2026-06-11 2026-06-11 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
548,580 +3.5%
7.91
US$4,339,268 		548,580 +3.5% 7.91 US$4,339,268
2026-06-11 2026-06-11 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
548,580 +3.5%
7.91
US$4,339,268 		548,580 +3.5% 7.91 US$4,339,268
2026-06-11 2026-06-10 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
103 +0.0%
7.00
US$721 		103 +0.0% 7.00 US$721
2026-06-11 2026-06-10 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
103 +0.0%
7.00
US$721 		103 +0.0% 7.00 US$721
2026-06-11 2026-06-09 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
479,039 +3.2%
6.91
US$3,310,159 		479,039 +3.2% 6.91 US$3,310,159
2026-05-19 2026-05-19 S Sale
1.3
Horan Christopher

Chief Tech Operations Officer

Officer
7,002 -2.3%
9.01
US$63,073 		7,002 -2.3% 9.01 US$63,073
2026-05-19 2026-05-19 S Sale
1.3
Aslan Fred

Chief Executive Officer

Executive Director
27,116 -1.7%
9.01
US$244,253 		27,116 -1.7% 9.01 US$244,253
2026-05-19 2026-05-19 S Sale
1.3
Banerjee Subhashis

Chief Medical Officer

Officer
7,037 -4.6%
9.01
US$63,386 		7,037 -4.6% 9.01 US$63,386
2026-05-19 2026-05-19 S Sale
1.3
Bush Jennifer

COO, CLO, Compliance Officer

Officer
8,790 -2.5%
9.01
US$79,179 		8,790 -2.5% 9.01 US$79,179
2026-05-19 2026-05-19 S Sale
1.3
Raymon Heather

SVP, Research and Development

Officer
3,095 -2.0%
9.01
US$27,879 		3,095 -2.0% 9.01 US$27,879
2026-05-18 2026-05-18 PrS Proposed sale
1.3
Fred Aslan, M.D.

Officer; Director

Executive Director
28,000
9.22
US$258,160 		28,000 9.22 US$258,160
2026-05-18 2026-05-18 PrS Proposed sale
1.3
Subhashis Banerjee

Officer; Director

Executive Director
7,000
9.22
US$64,540 		7,000 9.22 US$64,540
2026-05-18 2026-05-18 PrS Proposed sale
1.3
Jennifer Bush

Officer; Director

Executive Director
9,000
9.22
US$82,980 		9,000 9.22 US$82,980
2026-05-18 2026-05-18 PrS Proposed sale
1.3
Heather Raymon

Officer; Director

Executive Director
3,500
9.22
US$32,270 		3,500 9.22 US$32,270
2026-05-18 2026-05-18 PrS Proposed sale
1.3
Christopher P. Horan

Officer; Director

Executive Director
7,500
9.22
US$69,150 		7,500 9.22 US$69,150
2026-05-28 2026-05-11 B Purchase
1.3
GC Corp.
Large shareholder
347,222 +27.5%
11.52
US$3,999,997 		347,222 +27.5% 11.52 US$3,999,997
2026-05-28 2026-05-11 B Purchase
1.3
GC Corp.
Large shareholder
1,085,069 +32.8%
11.52
US$12,499,995 		1,085,069 +32.8% 11.52 US$12,499,995
2026-05-13 2026-05-11 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
6,510,416 +74.9%
11.52
US$74,999,992 		6,510,416 +74.9% 11.52 US$74,999,992
2025-12-15 2025-12-15 PrS Proposed sale
1.3
FRED ASLAN

Director; Officer

Executive Director
12,749
3.30
US$42,072 		12,749 3.30 US$42,072
2025-12-15 2025-12-15 PlS Planned sale
1.3
Aslan Fred

President and CEO

Executive Director
3,187 -0.3%
6.00
US$19,122 		3,187 -0.3% 6.00 US$19,122
2025-11-17 2025-11-17 PrS Proposed sale
1.3
FRED ASLAN

Director; Officer

Executive Director
6,375
3.25
US$20,719 		6,375 3.25 US$20,719
2025-11-17 2025-11-17 PlS Planned sale
1.3
Aslan Fred

President and CEO

Executive Director
6,375 -1.8%
3.38
US$21,522 		6,375 -1.8% 3.38 US$21,522
2025-10-17 2025-10-17 PrS Proposed sale
1.3
FRED ASLAN

Director; Officer

Executive Director
25,500
2.77
US$70,635 		25,500 2.77 US$70,635
2025-10-17 2025-10-17 PlS Planned sale
1.3
Aslan Fred

President and CEO

Executive Director
25,500 -6.7%
6.00
US$153,000 		25,500 -6.7% 6.00 US$153,000
2025-08-18 2025-08-15 PlS Planned sale
1.3
Aslan Fred

President and CEO

Executive Director
25,500 -6.2%
2.73
US$69,579 		25,500 -6.2% 2.73 US$69,579
2025-08-15 2025-08-15 PrS Proposed sale
1.3
FRED ASLAN

Director; Officer

Executive Director
25,500
2.70
US$68,850 		25,500 2.70 US$68,850
2024-07-24 2024-07-22 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
688,326 +497.0%
12.00
US$8,259,912 		688,326 +497.0% 12.00 US$8,259,912
2024-07-24 2024-07-22 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
7,645,007 +729.1%
12.00
US$91,740,084 		7,645,007 +729.1% 12.00 US$91,740,084
2024-07-24 2024-07-22 B Purchase
2.6
5AM Partners VI, LLC
Large shareholder
833,333 +239.0%
12.00
US$9,999,996 		833,333 +239.0% 12.00 US$9,999,996
2024-07-22 2024-07-22 B Purchase
1.3
GC Corp.
Large shareholder
416,666 +49.4%
12.00
US$4,999,992 		416,666 +49.4% 12.00 US$4,999,992
2024-07-22 2024-07-22 B Purchase
1.3
GC Corp.
Large shareholder
1,666,666 +101.6%
12.00
US$19,999,992 		1,666,666 +101.6% 12.00 US$19,999,992
2024-07-22 2024-07-22 B Purchase
2.9
venBio Global Strategic Fund III, L.P.
Large shareholder
416,666 +27.4%
12.00
US$4,999,992 		416,666 +27.4% 12.00 US$4,999,992
2024-07-22 2024-07-22 B Purchase
0.8
Huh Yong-Jun
Non-Executive Director
416,666 +49.4%
12.00
US$4,999,992 		416,666 +49.4% 12.00 US$4,999,992
2024-07-22 2024-07-22 B Purchase
0.8
Huh Yong-Jun
Non-Executive Director
1,666,666 +101.6%
12.00
US$19,999,992 		1,666,666 +101.6% 12.00 US$19,999,992
Explore more

More insider trading research around Artiva Biotherapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America